{
  "guid": "e926cf4e-6235-4f90-9130-acbd017f3f32",
  "title": "449. How to Fix the Incentives in Cancer Research",
  "description": "<p>For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another.</p>\n",
  "pubDate": "Thu, 28 Jan 2021 04:00:00 +0000",
  "author": "editor@freakonomics.com (Freakonomics Radio + Stitcher)",
  "link": "http://freakonomics.com/",
  "content:encoded": "<p>For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another.</p>\n",
  "enclosure": "",
  "itunes:title": "449. How to Fix the Incentives in Cancer Research",
  "itunes:author": "Freakonomics Radio + Stitcher",
  "itunes:image": "",
  "itunes:duration": "00:44:17",
  "itunes:summary": "For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another.",
  "itunes:subtitle": "For all the progress made in fighting cancer, it still kills 10 million people a year, and some types remain especially hard to detect and treat. Pancreatic cancer, for instance, is nearly always fatal. A new clinical-trial platform could change that by aligning institutions that typically compete against one another.",
  "itunes:explicit": "no",
  "itunes:episodeType": "full"
}